Tag Archives: orphan drug

Ardelyx Sets Specialty Pharmacy Limited Distribution Network for XPHOZAH®

AMI’s Specialty Pharmacy Database includes the list of limited distribution partners for hundreds of specialty pharmaceuticals as well as additional comprehensive information on 1,600 specialty pharmacies

Employer Plans View Product Coverage Very Differently from PBMs

Employers’ benefit coverage decisions and the impact those decisions have on the market for rare disease / orphan drugs are a growing concern for biopharma companies

Walmart, Biologics and Avita Care Solutions Headline Recent Specialty Pharmacy Activities

Walmart, Biologics and Avita Care Solutions Headline Recent Specialty Pharmacy Activities to consolidate and strengthen and expand their pharmacy reach and drug contracts

Did You Know Market Access is Closing Down

Biopharma companies need to see the employer market clearly in the short and long-term to be able to understand payers management methods for orphan drugs and the impact those decisions will have on their drugs

Independence Blue Cross Launches Gene Therapeutics Network

BlueCross Blue Shield Plans: Access Market Intelligence

Independence Blue Cross (Independence) recently announced the launch of its Advanced Network for Gene-Based Therapeutics, which will be effective March 1, 2023

Nobelpharma America Selects AllianceRx Walgreens and Total Care Rx to Distribute Hyftor

Nobelpharma America Selects AllianceRx Walgreens and Total Care Rx to Distribute Hyftor

Biologics by McKesson Selected to Provide VONJO and PYRUKYND

Biologics by McKesson continues to solidify its leadership position a provider for limited and exclusive drugs in the specialty pharmacy market

Biologics Selected by Agios Pharmaceuticals as Exclusive Distributor of PYRUKYND®

PYRUKYND prescriptions are processed exclusively through Biologics by McKesson to give patients a seamless experience